Legislative Session Starts; MMA to Focus on 5 Major Issues
February 19, 2026
State lawmakers returned to St. Paul on February 17 for the second half of the 2025-2026 biennium.
January 11, 2024
As of January 1, Minnesota patients with rare diseases will have better access to appropriate specialists who may be out-of-network.
Last session, the Legislature passed a "network access bill” that aims to reduce the diagnostic odyssey, address health equity and improve outcomes for Minnesotans with rare diseases.
The policy is geared toward any Minnesota resident with a diagnosis of a rare disease as defined by the Genetic and Rare Disease Center list, created by the National Institutes of Health (NIH). It also applies to those who:
have received two or more clinical consultations from a primary care provider or specialty provider that are specific to the presenting complaint;
and have documentation in the enrollee’s medical record of a developmental delay through standardized assessment, developmental regression, failure to thrive, or progressive multisystemic involvement;
and have had laboratory or clinical testing that failed to provide a definitive diagnosis or resulted in conflicting diagnoses.
For more information on access barriers, read the Minnesota Rare Disease Advisory Council's Healthcare Access Study here.
February 19, 2026
State lawmakers returned to St. Paul on February 17 for the second half of the 2025-2026 biennium.
February 19, 2026
On the second day of the legislative session, MMA leadership was already advocating for one of its top priorities - minimizing the harm of federal changes to Medical Assistance (MA).
February 19, 2026
Legislation to prohibit the use of artificial intelligence (AI) in prior authorization requirements was heard in the House Commerce Finance and Policy Committee on February 19.